Streetbeat News

DHAI

DIH Holding US Inc

Industry

Surgical and Medical Instrument Manufacturing

Open

0.30

Mkt cap

14M

Volume

593K

High

0.34

P/E Ratio

-0.94

52-wk high

3.67

Low

0.30

Div yield

N/A

52-wk low

0.28

12 health care stocks showed significant movements in Thursday's pre-market session. CNS Pharma (CNSP) saw the highest gain, rising 109.5%, while Gain Therapeutics (GANX) experienced the largest decline, falling 15.5%.

Portfolio Pulse from Benzinga Insights

July 05, 2024 | 2:59 pm

The article highlights the performance of 12 healthcare stocks during Tuesday's after-market session. Notable gainers include Reshape Lifesciences (RSLS), Dermata Therapeutics (DRMA), and Shuttle Pharmaceuticals (SHPH). Significant losers include Sharecare (SHCR), Reneo Pharmaceuticals (RPHM), and Sharps Technology (STSS).

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 8:31 pm

DIH Holding US, Inc. (NASDAQ:DHAI) has announced a strategic partnership with B-Temia Inc. to drive AI-based innovation in the rehabilitation market. This collaboration aims to enhance the quality of life for individuals needing functional rehabilitation and support.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:12 pm

In Monday's after-market session, several health care stocks experienced significant movements. Sharps Technology (NASDAQ:STSS) saw the highest gain with an 87% increase, while DIH Holding US (NASDAQ:DHAI) experienced the largest decline, dropping by 24.4%. Other notable gainers include MorphoSys (NASDAQ:MOR) and Kintara Therapeutics (NASDAQ:KTRA), while Innovative Eyewear (NASDAQ:LUCY) and Scinai Immunotherapeutics (NASDAQ:SCNI) were among the notable losers.

Portfolio Pulse from Benzinga Insights

May 27, 2024 | 8:31 pm

The article highlights the performance of 12 healthcare stocks during Friday's after-market session. Sharps Technology (STSS) saw the highest gain with a 50.5% increase, while DIH Holding US (DHAI) experienced the largest drop, falling 24.4%.

Portfolio Pulse from Benzinga Insights

May 24, 2024 | 8:31 pm

In Wednesday's after-market session, health care stocks saw significant movement. Trevena, Mustang Bio, SINTX Techs, Fortress Biotech, TC BioPharm, and Acutus Medical were among the gainers, with Trevena leading at a 27% increase. Conversely, TRACON Pharma, DIH Holding US, Virax Biolabs Group, Soligenix, INVO Bioscience, and ProKidney were the losers, with TRACON Pharma experiencing the largest decline at 16.6%. Market cap values varied, highlighting the volatility in the health care sector.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 8:31 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Notably, Better Therapeutics (BTTX) surged by 65.4%, while SELLAS Life Sciences Gr (SLS) dropped by 28.7%. Other notable gainers include Carmell (CTCX) and P3 Health Partners (PIII), with increases of 38.52% and 38.23% respectively. On the losing end, Immuneering (IMRX) and Lucy Scientific Discovery (LSDI) saw declines of 28.45% and 25.64%. These movements reflect the volatile nature of healthcare stocks in the market.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 5:31 pm

In Thursday's after-market session, health care stocks saw significant movements. Geron (GERN) led the gainers with a 90.8% increase, while Kineta (KA) experienced the largest drop among the losers, declining by 8.3%. Notably, Akebia Therapeutics (AKBA) rose by 8.02% following its Q4 earnings report.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:33 pm

Freshpet, Inc. (NASDAQ:FRPT) shares surged 15.5% after reporting Q4 earnings and sales above estimates. Other stocks also moved significantly in Monday's mid-day session, with notable gainers including Akili, Inc. (NASDAQ:AKLI), ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA), and MicroCloud Hologram Inc. (NASDAQ:HOLO), among others. Losers included Aclarion, Inc. (NASDAQ:ACON) and Venus Concept Inc. (NASDAQ:VERO).

Portfolio Pulse from Avi Kapoor

February 26, 2024 | 6:57 pm

IPG Photonics Corporation's shares fell by 11% after reporting mixed Q4 financial results and soft Q1 guidance. Other stocks showed significant movements, with notable gainers including Ohmyhome Limited, BioNexus Gene Lab Corp, and Digital Brands Group, Inc., among others. Losers included BIOLASE, Inc., Sunshine Biopharma, Inc., and Sientra, Inc., with significant drops after various announcements.

Portfolio Pulse from Avi Kapoor

February 13, 2024 | 6:13 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.